Search Results - Chen, Zaowen
- Showing 1 - 9 results of 9
-
1
-
2
-
3
-
4
-
5
MYCN acts as a direct co-regulator of p53 in MYCN amplified neuroblastoma by Agarwal, Saurabh, Milazzo, Giorgio, Rajapakshe, Kimal, Bernardi, Ronald, Chen, Zaowen, Barberi, Eveline, Koster, Jan, Perini, Giovanni, Coarfa, Cristian, Shohet, Jason M.
Published 2018Text -
6
Correction: MYCN acts as a direct co-regulator of p53 in MYCN amplified neuroblastoma by Agarwal, Saurabh, Milazzo, Giorgio, Rajapakshe, Kimal, Bernardi, Ronald, Chen, Zaowen, Eveline, Barbieri, Koster, Jan, Perini, Giovanni, Coarfa, Cristian, Shohet, Jason M.
Published 2018Text -
7
A p53 Drug Response Signature Identifies Prognostic Genes in High-Risk Neuroblastoma by Barbieri, Eveline, De Preter, Katleen, Capasso, Mario, Johansson, Peter, Man, Tsz-Kwong, Chen, Zaowen, Stowers, Paris, Tonini, Gian Paolo, Speleman, Frank, Shohet, Jason M.
Published 2013Text -
8
G-CSF Receptor Positive Neuroblastoma Subpopulations are Enriched in Chemotherapy –Resistant or Relapsed Tumors and are Highly Tumorigenic by Hsu, Danielle M., Agarwal, Saurabh, Benham, Ashley, Coarfa, Cristian, Trahan, Denae N., Chen, Zaowen, Stowers, Paris N., Courtney, Amy N., Lakoma, Anna, Barbieri, Eveline, Metelitsa, Leonid S., Gunaratne, Preethi, Kim, Eugene S., Shohet, Jason M.
Published 2013Text -
9
p53 Nongenotoxic Activation and mTORC1 Inhibition Lead to Effective Combination for Neuroblastoma Therapy by Moreno-Smith, Myrthala, Lakoma, Anna, Chen, Zaowen, Tao, Ling, Scorsone, Kathleen A., Schild, Linda, Aviles-Padilla, Kevin, Nikzad, Rana, Zhang, Yankai, Chakraborty, Rikhia, Molenaar, Jan J., Vasudevan, Sanjeev A., Sheehan, Vivien, Kim, Eugene S., Paust, Silke, Shohet, Jason M., Barbieri, Eveline
Published 2017Text